Comparison of the efficacy and acute toxicity of weekly versus daily chemoradiotherapy for non-small-cell lung cancer: A meta-analysis

International Journal of Radiation Oncology Biology Physics

Volumn 58, Issue 1, 2004, Pages 196-203

  Rakovitch, Eileen ^a   Tsao, May ^a   Ung, Yee ^a   Pignol, Jean Philippe ^a   Cheung, Patrick ^a   Chow, Edward ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Chemotherapy; Concurrent chemoradiotherapy; Meta analysis; Non small cell lung cancer; Radiotherapy

Indexed keywords

BIOLOGICAL ORGANS; CHEMOTHERAPY; RADIOTHERAPY; STATISTICAL METHODS; TOXICITY; TUMORS;

MORTALITY;

ONCOLOGY;

CARBOPLATIN; CISPLATIN; VINBLASTINE;

ACUTE TOXICITY; CANCER CHEMOTHERAPY; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DISEASE COURSE; DRUG MEGADOSE; ESOPHAGITIS; HUMAN; LOW DRUG DOSE; LUNG NON SMALL CELL CANCER; META ANALYSIS; MORTALITY; NEUTROPENIA; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZATION; REVIEW;

EID: 0347624514     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)01447-0     Document Type: Article

References (22)

1. Jemal A., Thomas A., Murray T., et al. Cancer statistics, 2002. [erratum CA Cancer J Clin 2002;52:119] CA Cancer J Clin. 52:2002;23-47.
2. Dillman R.O., Seagren S.L., Propert K.J., et al. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med. 323:1990;940-945.
3. Le Chevalier T, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: First analysis of a randomized trial in 353 patients. J Natl Cancer Inst 1991;20;83:417-423.
4. Pritchard R.S., Anthony S.P. Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis. [erratum Ann Intern Med 1997;126:670] Ann Intern Med. 125:1996;723-729.
5. Curran WJ, Scott C, Langer C, et al. Phase III comparison of sequential vs concurrent chemoradiation for PTS with unresected stage III non-small lung cancer (NSCLC): Initial report of RTOG 9410 [Abstract]. Proc ASCO 2000;19:484a.
6. Furuse K., Fukuoka M., Kawahara M., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol. 17:1999;2692-2699.
7. Bonner J.A., McGinnis W.L., Stella P.J., et al. The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma Results of a North Central Cancer Treatment Group phase III study . Cancer. 82:1998;1037-1048.
8. Jeremic B., Shibamoto Y., Acimovic L., et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/ etoposide for stage III non-small-cell lung cancer A randomized study . J Clin Oncol. 14:1996;1065-1070.
9. Schaake-Koning C, van den Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 1992;326:524-530.
10. Trovo M.G., Minatel E., Franchin G., et al. Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 24:1992;11-15.
11. Blanke C., Ansari R., Mantravadi R., et al. Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer A Hoosier Oncology Group protocol . J Clin Oncol. 13:1995;1425-1429.
12. Clamon G., Herndon J., Cooper R., et al. Radiosensitization with carboplatin for patients with unresectable stage III non-small-cell lung cancer A phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group . J Clin Oncol. 17:1999;4-11.
13. Jeremic B., Shibamoto Y., Acimovic L., et al. Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer. J Clin Oncol. 13:1995;452-458.
14. Johnson D.H., Einhorn L.H., Bartolucci A., et al. Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer. Ann Intern Med. 113:1990;33-38.
15. Dewit L. Combined treatment of radiation and cisdiamminedichloroplatinum (II) A review of experimental and clinical data . Int J Radiat Oncol Biol Phys. 13:1987;403-426.
16. Devita VT, Hellman S, Rosenberg SA. Cancer: Principles and practice of oncology. 5th ed. Philadelphia: Lippincott-Raven; 2003.
17. Ball D., Bishop J., Smith J., et al. A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer Final report of an Australian multi-centre trial . Radiother Oncol. 52:1999;129-136.
18. Jeremic B., Jevremovic S., Mijatovic L., et al. Hyperfractionated radiation therapy with and without concurrent chemotherapy for advanced non-small cell lung cancer. Cancer. 71:1993;3732-3736.
19. Soresi E, Clerici M, Grilli R, et al. A randomized clinical trial comparing radiation therapy v radiation therapy plus cis-dichlorodiammine platinum (II) in the treatment of locally advanced non-small cell lung cancer. Semin Oncol 1988;15(6 Suppl. 7):20-25.
20. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials. 7:1986;177-188.
21. Fietkau R. Concomitant radiochemotherapy of advanced non-small-cell lung cancer. Lung Cancer. 33:(Suppl.):2001;S65-76.
22. Pignon J.P., Bourhis J., Domenge C., et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma Three meta-analyses of updated individual data - MACH-NC Collaborative Group, Meta-Analysis of Chemotherapy on Head and Neck Cancer . Lancet. 355:2000;949-955.